Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Wegovy, which has been used for weight loss reasons, is not going to be covered ... this is for whatever the indication is, even though it is intended for weight loss, just to get around this?

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Women using weight-loss jabs have been warned that they must use effective contraception because of fears the medicines could harm an unborn baby. Wegovy ... it is a useful indication of whether ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the first glucagon-like peptide-1 (GLP-1) agonist to treat Type 2 diabetes. But ...

Adolescents face significant barriers to obesity medication access, despite a surge in prescriptions. Discover the ...

2013: The U.S. Food and Drug Administration issues a warning letter to 23andMe to stop selling its genetic tests due to concerns that it failed to provide any indication that it had analytically ...